News Industry News CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018 May 24, 2018
News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Industry News Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin January 22, 2018